Liquidia Corporation (LQDA) Financials

LQDA Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 120.4 million 73.1 million
2023-09-30 111.6 million 63.6 million
2023-06-30 121.6 million 60.9 million
2023-03-31 128.9 million 47.3 million

LQDA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -16.2 million 2.6 million
2023-09-30 -22.0 million 2.5 million
2023-06-30 -5.8 million 2.5 million
2023-03-31 -8.8 million 2.6 million

LQDA Net Income

No data available :(

LQDA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 83.7 million - 3.5 million
2023-09-30 76.2 million - 3.8 million
2023-06-30 88.2 million - 4.0 million
2023-03-31 94.4 million - 4.3 million

LQDA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 65.4 million
2023-09-30 64.9 million
2023-06-30 64.8 million
2023-03-31 64.7 million

LQDA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 206000 12.6 million 17.1 million -
2023-09-30 10.5 million 7.4 million 10.6 million -
2023-06-30 243000 17.7 million 9.2 million -
2023-03-31 366000 5.3 million 7.8 million -

LQDA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 4.5 million 1.3 million
2023-09-30 3.7 million 570000
2023-06-30 4.8 million 671000
2023-03-31 4.5 million 654000

LQDA

Price: $12.98

52 week price:
5.71
16.99

Earnings Per Share: -1.21 USD

P/E Ratio: -16.82

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 65756

Market Capitalization: 1.0 billion

Links: